日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry

首次使用JAK抑制剂后二线治疗的特征分析:来自CorEvitas类风湿性关节炎注册研究的结果

Baker, Joshua F; Mizelle, Kristi V; Saikali, Wassim; Moore, Page C; Kang, Hyung-Joo; Gruben, David; Shelbaya, Ahmed; Stockert, Lori; O'Brien, Jacqueline

Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry

托法替尼与肿瘤坏死因子抑制剂相比的疗效,以及托法替尼作为不同治疗方案在类风湿性关节炎患者中的疗效:来自美国CorEvitas类风湿性关节炎注册研究的结果

Harrold, Leslie R; Bingham, Clifton O; Pope, Janet E; O'Brien, Jacqueline; Moore, Page C; Roberts-Toler, Carla; Yu, Miao; Sweet, Lindsay L; Shelbaya, Ahmed; Masri, Karim R

Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease

疲劳对炎症性肠病患者工作效率、活动能力受损和医疗资源利用的影响

Feagins, Linda A; Moore, Page; Crabtree, Margaux M; Eliot, Melissa; Lemay, Celeste A; Loughlin, Anita M; Gaidos, Jill K J

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting

在真实世界环境中,接受英夫利昔单抗生物类似药 IFX-dyyb 治疗的类风湿性关节炎患者的特征和 6 个月疗效

Baker, Joshua F; Bakewell, Catherine; Dikranian, Ara; Lam, Gordon; O'Brien, Jacqueline; Moore, Page C; Yu, Miao; Hur, Peter; Masri, Karim R

Prevalence and Factors Associated With Patient-Clinician Discordance Among Patients With Rheumatoid Arthritis Initiating Advanced Therapy

类风湿性关节炎患者开始接受高级治疗时,患者与临床医生意见不一致的发生率及相关因素

Curtis, Jeffrey R; McLean, Robert R; Lee, I-Heng; Mackey, Rachel H; Moore, Page C; Haubrich, Richard; Greenberg, Jeffrey D; Wu, Alicea

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

Brentuximab vedotin联合AVD治疗II-IV期HIV相关霍奇金淋巴瘤(AMC 085):一项开放标签、单臂、多中心1/2期试验的2期结果

Rubinstein, Paul G; Moore, Page C; Bimali, Milan; Lee, Jeanette Y; Rudek, Michelle A; Chadburn, Amy; Ratner, Lee; Henry, David H; Cesarman, Ethel; DeMarco, Camille E; Costagliola, Dominique; Taoufik, Yassine; Ramos, Juan Carlos; Sharon, Elad; Reid, Erin G; Ambinder, Richard F; Mitsuyasu, Ronald; Mounier, Nicolas; Besson, Caroline; Noy, Ariela

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP

阿巴西普与托法替尼在类风湿性关节炎合并慢性疼痛综合征患者中的疗效比较

Harrold, Leslie R; Wittstock, Keith; Kelly, Sheila; Han, Xue; Shan, Ying; Guo, Lin; Moore, Page C; Khaychuk, Vadim

Change in Urgency Status Among Ulcerative Colitis Patients: Understanding a Potential Unmet Patient Need From the CorEvitas Inflammatory Bowel Disease Registry

溃疡性结肠炎患者就诊急迫程度的变化:从CorEvitas炎症性肠病登记数据中了解潜在的未满足患者需求

Wolf, Douglas C; Naegeli, April N; Moore, Page C; Janak, Jud C; Crabtree, Margaux M; Shan, Mingyang; Hunter, Theresa M; Sontag, Angelina; Cross, Raymond K

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.

AMC-070:来那度胺对 HIV 相关卡波西肉瘤安全有效

Reid Erin G, Shimabukuro Kelly, Moore Page, Ambinder Richard F, Bui Jack D, Han Semi, Martínez-Maza Otoniel, Dittmer Dirk P, Aboulafia David, Chiao Elizabeth Yu, Maurer Toby, Baiocchi Robert, Mitsuyasu Ronald, Wachsman William

Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study

卡铂和紫杉醇在 HIV 合并癌症患者中的安全性和耐受性 (AMC-078),一项艾滋病恶性肿瘤联盟 (AMC) 研究

Haigentz, Missak; Moore, Page; Bimali, Milan; Cooley, Timothy; Sparano, Joseph; Rudek, Michelle; Ratner, Lee; Henry, David; Ramos, Juan; Deeken, John; Rubinstein, Paul; Chiao, Elizabeth